CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer

Background. Carboxypeptidase A4 (CPA4) belongs to a member of the metallocarboxypeptidase family, and its expression in lung cancer samples and clinical significance are still not investigated until now. In this study, we aimed to evaluate the level of CPA4 in non-small-cell lung cancer (NSCLC) samp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Sun, Lichao, Wang, Yipeng, Yuan, Hebao, Burnett, Joseph, Pan, Jian, Yang, Zhihua, Ran, Yuliang, Myers, Ila, Sun, Duxin
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4934027/
https://ncbi.nlm.nih.gov/pubmed/27390594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.15209
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki